| Clinical significance of serum expression of GRObeta in esophageal squamous cell carcinoma. | esophageal, |
| Data suggest that GRObeta may function as an oncogene product and contribute to tumorigenesis and metastasis of esophageal squamous cell carcinoma. | esophageal, |
| We have demonstrated that GRObeta, as an oncogene product, contributed to tumorigenesis and metastasis of HCC | liver, |
| The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. | None |
| Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven-transmembrane oncogene product, ORF-74. | None |